{"id":9822,"date":"2025-10-30T10:05:19","date_gmt":"2025-10-30T09:05:19","guid":{"rendered":"https:\/\/www.seventure.fr\/?p=9822"},"modified":"2025-10-31T10:08:35","modified_gmt":"2025-10-31T09:08:35","slug":"tubulis-announces-second-closing-of-series-c-bringing-total-raised-to-e344m-us-401m","status":"publish","type":"post","link":"https:\/\/www.seventure.fr\/en\/tubulis-announces-second-closing-of-series-c-bringing-total-raised-to-e344m-us-401m\/","title":{"rendered":"Tubulis Announces Second Closing of Series C Bringing Total Raised to \u20ac344M (US $ 401M)"},"content":{"rendered":"","protected":false},"excerpt":{"rendered":"","protected":false},"author":8,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[101,106],"tags":[],"class_list":["post-9822","post","type-post","status-publish","format-standard","hentry","category-life-sciences-en","category-biotech-pharmaceuticals"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Tubulis Announces Second Closing of Series C Bringing Total Raised to \u20ac344M (US $ 401M) | Seventure<\/title>\n<meta name=\"description\" content=\"\u2022 New investors Fidelity Management &amp; Research Company, Janus Henderson Investors and Blackstone Multi-Asset Investing join Series C syndicate led by Venrock Healthcare Capital Partners \u2022 Funding will accelerate TUB-040 development to broaden its potential for patients following compelling first clinical results presented at ESMO 2025 and advance the company\u2019s pipeline and ADC-technology innovation\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.seventure.fr\/en\/tubulis-announces-second-closing-of-series-c-bringing-total-raised-to-e344m-us-401m\/\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Romane Brunet\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.seventure.fr\\\/en\\\/tubulis-announces-second-closing-of-series-c-bringing-total-raised-to-e344m-us-401m\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.seventure.fr\\\/en\\\/tubulis-announces-second-closing-of-series-c-bringing-total-raised-to-e344m-us-401m\\\/\"},\"author\":{\"name\":\"Romane Brunet\",\"@id\":\"https:\\\/\\\/www.seventure.fr\\\/en\\\/#\\\/schema\\\/person\\\/990cba5bd0870778fd29b092bb2bacd5\"},\"headline\":\"Tubulis Announces Second Closing of Series C Bringing Total Raised to \u20ac344M (US $ 401M)\",\"datePublished\":\"2025-10-30T09:05:19+00:00\",\"dateModified\":\"2025-10-31T09:08:35+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.seventure.fr\\\/en\\\/tubulis-announces-second-closing-of-series-c-bringing-total-raised-to-e344m-us-401m\\\/\"},\"wordCount\":14,\"articleSection\":[\"Life Sciences\",\"Biotech &amp; Pharmaceuticals\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.seventure.fr\\\/en\\\/tubulis-announces-second-closing-of-series-c-bringing-total-raised-to-e344m-us-401m\\\/\",\"url\":\"https:\\\/\\\/www.seventure.fr\\\/en\\\/tubulis-announces-second-closing-of-series-c-bringing-total-raised-to-e344m-us-401m\\\/\",\"name\":\"Tubulis Announces Second Closing of Series C Bringing Total Raised to \u20ac344M (US $ 401M) | Seventure\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.seventure.fr\\\/en\\\/#website\"},\"datePublished\":\"2025-10-30T09:05:19+00:00\",\"dateModified\":\"2025-10-31T09:08:35+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.seventure.fr\\\/en\\\/#\\\/schema\\\/person\\\/990cba5bd0870778fd29b092bb2bacd5\"},\"description\":\"\u2022 New investors Fidelity Management & Research Company, Janus Henderson Investors and Blackstone Multi-Asset Investing join Series C syndicate led by Venrock Healthcare Capital Partners \u2022 Funding will accelerate TUB-040 development to broaden its potential for patients following compelling first clinical results presented at ESMO 2025 and advance the company\u2019s pipeline and ADC-technology innovation\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.seventure.fr\\\/en\\\/tubulis-announces-second-closing-of-series-c-bringing-total-raised-to-e344m-us-401m\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.seventure.fr\\\/en\\\/tubulis-announces-second-closing-of-series-c-bringing-total-raised-to-e344m-us-401m\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.seventure.fr\\\/en\\\/tubulis-announces-second-closing-of-series-c-bringing-total-raised-to-e344m-us-401m\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\\\/\\\/www.seventure.fr\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Tubulis Announces Second Closing of Series C Bringing Total Raised to \u20ac344M (US $ 401M)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.seventure.fr\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/www.seventure.fr\\\/en\\\/\",\"name\":\"Seventure\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.seventure.fr\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.seventure.fr\\\/en\\\/#\\\/schema\\\/person\\\/990cba5bd0870778fd29b092bb2bacd5\",\"name\":\"Romane Brunet\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/efe58eeb7d12f67249bb906294dace961dd1ea505113759a9a2820da1ffaa1ec?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/efe58eeb7d12f67249bb906294dace961dd1ea505113759a9a2820da1ffaa1ec?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/efe58eeb7d12f67249bb906294dace961dd1ea505113759a9a2820da1ffaa1ec?s=96&d=mm&r=g\",\"caption\":\"Romane Brunet\"},\"url\":\"https:\\\/\\\/www.seventure.fr\\\/en\\\/author\\\/romane-brunet\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Tubulis Announces Second Closing of Series C Bringing Total Raised to \u20ac344M (US $ 401M) | Seventure","description":"\u2022 New investors Fidelity Management & Research Company, Janus Henderson Investors and Blackstone Multi-Asset Investing join Series C syndicate led by Venrock Healthcare Capital Partners \u2022 Funding will accelerate TUB-040 development to broaden its potential for patients following compelling first clinical results presented at ESMO 2025 and advance the company\u2019s pipeline and ADC-technology innovation","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.seventure.fr\/en\/tubulis-announces-second-closing-of-series-c-bringing-total-raised-to-e344m-us-401m\/","twitter_misc":{"Written by":"Romane Brunet"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.seventure.fr\/en\/tubulis-announces-second-closing-of-series-c-bringing-total-raised-to-e344m-us-401m\/#article","isPartOf":{"@id":"https:\/\/www.seventure.fr\/en\/tubulis-announces-second-closing-of-series-c-bringing-total-raised-to-e344m-us-401m\/"},"author":{"name":"Romane Brunet","@id":"https:\/\/www.seventure.fr\/en\/#\/schema\/person\/990cba5bd0870778fd29b092bb2bacd5"},"headline":"Tubulis Announces Second Closing of Series C Bringing Total Raised to \u20ac344M (US $ 401M)","datePublished":"2025-10-30T09:05:19+00:00","dateModified":"2025-10-31T09:08:35+00:00","mainEntityOfPage":{"@id":"https:\/\/www.seventure.fr\/en\/tubulis-announces-second-closing-of-series-c-bringing-total-raised-to-e344m-us-401m\/"},"wordCount":14,"articleSection":["Life Sciences","Biotech &amp; Pharmaceuticals"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.seventure.fr\/en\/tubulis-announces-second-closing-of-series-c-bringing-total-raised-to-e344m-us-401m\/","url":"https:\/\/www.seventure.fr\/en\/tubulis-announces-second-closing-of-series-c-bringing-total-raised-to-e344m-us-401m\/","name":"Tubulis Announces Second Closing of Series C Bringing Total Raised to \u20ac344M (US $ 401M) | Seventure","isPartOf":{"@id":"https:\/\/www.seventure.fr\/en\/#website"},"datePublished":"2025-10-30T09:05:19+00:00","dateModified":"2025-10-31T09:08:35+00:00","author":{"@id":"https:\/\/www.seventure.fr\/en\/#\/schema\/person\/990cba5bd0870778fd29b092bb2bacd5"},"description":"\u2022 New investors Fidelity Management & Research Company, Janus Henderson Investors and Blackstone Multi-Asset Investing join Series C syndicate led by Venrock Healthcare Capital Partners \u2022 Funding will accelerate TUB-040 development to broaden its potential for patients following compelling first clinical results presented at ESMO 2025 and advance the company\u2019s pipeline and ADC-technology innovation","breadcrumb":{"@id":"https:\/\/www.seventure.fr\/en\/tubulis-announces-second-closing-of-series-c-bringing-total-raised-to-e344m-us-401m\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.seventure.fr\/en\/tubulis-announces-second-closing-of-series-c-bringing-total-raised-to-e344m-us-401m\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.seventure.fr\/en\/tubulis-announces-second-closing-of-series-c-bringing-total-raised-to-e344m-us-401m\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/www.seventure.fr\/en\/"},{"@type":"ListItem","position":2,"name":"Tubulis Announces Second Closing of Series C Bringing Total Raised to \u20ac344M (US $ 401M)"}]},{"@type":"WebSite","@id":"https:\/\/www.seventure.fr\/en\/#website","url":"https:\/\/www.seventure.fr\/en\/","name":"Seventure","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.seventure.fr\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.seventure.fr\/en\/#\/schema\/person\/990cba5bd0870778fd29b092bb2bacd5","name":"Romane Brunet","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/efe58eeb7d12f67249bb906294dace961dd1ea505113759a9a2820da1ffaa1ec?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/efe58eeb7d12f67249bb906294dace961dd1ea505113759a9a2820da1ffaa1ec?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/efe58eeb7d12f67249bb906294dace961dd1ea505113759a9a2820da1ffaa1ec?s=96&d=mm&r=g","caption":"Romane Brunet"},"url":"https:\/\/www.seventure.fr\/en\/author\/romane-brunet\/"}]}},"_links":{"self":[{"href":"https:\/\/www.seventure.fr\/en\/wp-json\/wp\/v2\/posts\/9822","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.seventure.fr\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.seventure.fr\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.seventure.fr\/en\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/www.seventure.fr\/en\/wp-json\/wp\/v2\/comments?post=9822"}],"version-history":[{"count":2,"href":"https:\/\/www.seventure.fr\/en\/wp-json\/wp\/v2\/posts\/9822\/revisions"}],"predecessor-version":[{"id":9824,"href":"https:\/\/www.seventure.fr\/en\/wp-json\/wp\/v2\/posts\/9822\/revisions\/9824"}],"wp:attachment":[{"href":"https:\/\/www.seventure.fr\/en\/wp-json\/wp\/v2\/media?parent=9822"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.seventure.fr\/en\/wp-json\/wp\/v2\/categories?post=9822"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.seventure.fr\/en\/wp-json\/wp\/v2\/tags?post=9822"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}